FDA 483 - Microtransponder Inc. - August 29, 2025

Microtransponder Inc. in Minneapolis, MN, a medical device manufacturer, was inspected by the FDA. The inspection revealed significant deficiencies in the firm's complaint handling procedures. Specifically, investigations for several complaints were inadequate, delays in processing complaints were not justified, and the firm failed to adequately document how similar complaints would be identified as a trend requiring corrective action.